Mapletree Pan Asia Commercial Trust

“MPACT's VivoCity and MBC anchors are genuinely high-quality assets, but the 2022 MNACT merger permanently impaired the portfolio by adding structurally declining China office, Hong Kong retail, and FX-headwind Japan/Korea exposure — all managed by a sponsor whose fee structure prioritises AUM over unitholder returns. DPU has declined for three consecutive years, gearing is near the 50% regulatory ceiling, NAV is at risk of further North Asia writedowns, and there is no credible reinvestment or divestment pathway to reverse the trajectory. At SGD 1.40 (0.80x P/NAV, ~5-6% forward yield on a declining distribution), the market is pricing in the impairment but not yet the full downside risk of a forced equity raise or further asset devaluations. Capital is better deployed in higher-quality Singapore REITs or elsewhere entirely.”